BioSpace

FDA Action Date for Sanofi’s Oral Multiple Sclerosis Drug Bumped to December

The company was expecting a decision from the FDA by Sept. 28 for its oral drug tolebrutinib, but an update to the drug’s ...
The Malaysian Reserve

Goodfin and NYU Stern Professor Srikanth Jagabathula Release Landmark Study Showing AI Models Perform at a Level Above and Beyond the CFA Level III Exam Standards

AI Wealth Platform Goodfin Unveils that AI Can Now Master the Highest Levels of Financial Certification SAN FRANCISCO, Sept. 22, 2025 /PRNewswire/ -- ...